Tech Company Financing Transactions

Override Funding Round

7wire Ventures, Martin Ventures and Confluent Health participated in a $3.5 million Seed funding round for Override. The round was announced on 12/16/2022.

Transaction Overview

Company Name
Announced On
12/16/2022
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Seed
Investors
Proceeds Purpose
Override, a Philadelphia, PA-based new multi-specialty, virtual chronic pain solution, raised $3.5m in seed funding.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
944 Merion Square Road
Gladwyne, PA 19035
USA
Phone
Undisclosed
Email Address
Overview
Operator of a digital healthcare company intended to offer services to control chronic pain. The company provides services to control pain through pain physicians, pain-trained physical therapists, pain psychologists, and certified pain coaches, helping patients to overcome chronic pain and get recovered.
Profile
Override LinkedIn Company Profile
Social Media
Override Company Twitter Account
Company News
Override News
Facebook
Override on Facebook
YouTube
Override on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Shulkin
  David Shulkin LinkedIn Profile  David Shulkin Twitter Account  David Shulkin News  David Shulkin on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/16/2022: K1x venture capital transaction
Next: 12/16/2022: PaxeraHealth venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary